My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$ABBV {{ '2015-07-24T13:48:10+0000' | timeago}} • Webcast

$ABBV 2Q15 Call: The acquisition of Pharmacyclics will also drive strong financial benefits, further diversifying our revenue base significantly enhancing our revenue growth. We expect accretion related to the acquisition in excess of $0.60 per share in 2019 ramping to more than a dollar per share in 2021.

User Andy Anger {{ '2017-04-26T00:52:34+0000' | timeago}}

STRP going to $150. Another counter offer will come.

User Sebastian Calvo Goicoechea {{ '2017-04-25T18:43:34+0000' | timeago}}

$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th

User Nick Velez {{ '2017-04-25T15:32:14+0000' | timeago}}

Aramco valuation only $1.5 trillion: WSJ

User Leroy John {{ '2017-04-25T14:59:07+0000' | timeago}}

As part of reorganization, specialty retailer J. Crew Group plans to cut 250 jobs primarily from its corporate headquarters. About 150 full-time jobs and 100 open positions will be cut.

User Rachel Hicks {{ '2017-04-25T14:04:02+0000' | timeago}}

Wow! $MCD scores again.

$UTX {{ '2017-04-26T13:29:31+0000' | timeago}} • Webcast

At 1Q17-end, $UTX's inventories grew about $680MM, driven by Pratt & Whitney which totals about $4Bil of inventories. Engine building is ramping up, with 160 engines in 2016 to 350-400 in 2017 and doubling again in 2018. The company said this ramp up will improve the inventory turns and the inventory balance will be in line over the next 18 months.

$DPS {{ '2017-04-26T13:27:37+0000' | timeago}} • Announcement

$DPS now expects 2017 core EPS of $4.56-4.66 and its core tax rate to be about 34%.  The company now expects to invest an incremental $10MM in marketing investments above its previous guidance. $DPS still expects to repurchase common shares of $450-500MM and capital spending to be about 3% of net sales.

$BAX {{ '2017-04-26T13:26:46+0000' | timeago}} • Announcement

$BAX's global sales for Hospital Products totaled $1.6Bil in 1Q17, up 7% on both a reported and constant currency basis. Renal sales totaled $896MM, up 1% globally on a constant currency basis.

$TWTR {{ '2017-04-26T13:26:16+0000' | timeago}} • Webcast

$TWTR said that it will have some incremental investments in 2Q17 in marketing and headcount. The company plans to increase its headcount steadily throughout the year. $TWTR plans for key hires in the areas of engineering, product and design.

$DPS {{ '2017-04-26T13:24:40+0000' | timeago}} • Announcement

$DPS expects 2017 organic volume growth to be just over 1% and total volume growth of about 2%, inclusive of the Bai acquisition, which closed on Jan. 31, 2017. Net sales growth is now expected to be about 4%, including about 1 point of negative foreign currency translation and also includes the Bai acquisition.